GRACEcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.

Dr. Greg Riely offers his view on the best way to approach the common scenario of an EGFR mutation or other "driver mutation" being identified after a patient is already on first line chemotherapy. When should we switch from one treatment to another?

Direct download: GRACEcastUC-069_Lung-Video_Riely_on_EGFR_Mutation_After_Chemo.m4v
Category:Lung-Cancer-Video -- posted at: 12:00am PDT

Dr. Oxnard from Dana Farber Cancer Institute provides his insight on which patients with advanced non-small cell lung cancer he pursues molecular testing for, and which molecular markers are the highest priority.

Direct download: GRACEcastUC-068_Lung-Video_Oxnard_on_Molecular_Marker_Testing.m4v
Category:Lung-Cancer-Video -- posted at: 11:59pm PDT

Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, describes new targets for squamous cell non-small cell lung cancer and anti-PD1 immunotherapy that has emerged as one of the most promising new developments in lung cancer from 2012.

Direct download: GRACEcast-145_Lung-Video_Leighl_Highlights_Squam_and_antiPD1.m4v
Category:Lung-Cancer-Video -- posted at: 6:32pm PDT

Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, describes new targets for squamous cell non-small cell lung cancer and anti-PD1 immunotherapy that has emerged as one of the most promising new developments in lung cancer from 2012.

Direct download: GRACEcast-145_Lung-Audio_Leighl_Highlights_Squam_and_antiPD1.mp3
Category:Lung-Cancer-Audio -- posted at: 6:31pm PDT

Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, reviews exciting new data illustrating the potential benefits of the MEK inhibitor selumetinib in treating KRAS mutation-positive advanced non-small cell lung cancer.

Direct download: GRACEcast-144_Lung-Video_Leighl_Highlights_MEK_KRAS_Mutation.m4v
Category:Lung-Cancer-Video -- posted at: 4:46pm PDT

Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, reviews exciting new data illustrating the potential benefits of the MEK inhibitor selumetinib in treating KRAS mutation-positive advanced non-small cell lung cancer.

Direct download: GRACEcast-144_Lung-Audio_Leighl_Highlights_MEK_KRAS_Mutation.mp3
Category:Lung-Cancer-Audio -- posted at: 4:46pm PDT

Dr. Matthew Katz, surgeon at MD Anderson Cancer Center, reviews the general concept of cancer staging, the basic workup and staging of pancreatic cancer, and the implications of this process on treatment recommendations.


Dr. Matthew Katz, surgeon at MD Anderson Cancer Center, reviews the general concept of cancer staging, the basic workup and staging of pancreatic cancer, and the implications of this process on treatment recommendations.


Dr. Matthew Katz, surgeon at MD Anderson Cancer Center, provides a general introduction to the form and function of the pancreas, along with a description of the magnitude of the impact of pancreatic cancer in the US.


Dr. Matthew Katz, surgeon at MD Anderson Cancer Center, provides a general introduction to the form and function of the pancreas, along with a description of the magnitude of the impact of pancreatic cancer in the US.